Compare AIMD & ULY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AIMD | ULY |
|---|---|---|
| Founded | 1984 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2M | 4.0M |
| IPO Year | N/A | N/A |
| Metric | AIMD | ULY |
|---|---|---|
| Price | $1.63 | $2.87 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $11.50 |
| AVG Volume (30 Days) | 27.0K | ★ 442.9K |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $113,037.00 | ★ $127,932,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $18.95 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 178.19 | N/A |
| 52 Week Low | $1.70 | $1.74 |
| 52 Week High | $5.00 | $17.99 |
| Indicator | AIMD | ULY |
|---|---|---|
| Relative Strength Index (RSI) | 28.06 | 64.13 |
| Support Level | $1.94 | $1.80 |
| Resistance Level | $2.01 | $2.26 |
| Average True Range (ATR) | 0.12 | 0.34 |
| MACD | -0.02 | 0.08 |
| Stochastic Oscillator | 3.40 | 50.25 |
Ainos Inc is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. It combines AI and Nose, redefining machine perception for the sensory age.
Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.